Postpartum Depression (PPD) Treatment: Introduction

  • Postpartum depression (PPD) affects some women after giving birth to a baby. Key symptoms are anxiety, changes in sleeping & eating patterns, sadness, low energy, and irritability.
  • PPD develops within 4 weeks to 6 weeks after giving birth or could appear after a few months of delivery. It does not affect all pregnant women; however, is seen mostly after 3 months to 6 months of childbirth. This could lead to symptoms affecting psychological behavior such as low mood that lasts for longer than a week, crying, reduced motivation, and feeling of inadequacy.
  • Physical changes of pregnancy, complicated or difficult labor, loneliness, a history of mental health problems, and hormonal changes are the other factors contributing to PPD
  • Postpartum depression (PPD) treatment includes counseling, help of support groups, and medications

Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure of Postpartum Depression (PPD) Treatment Market Report

Key Drivers of Global Postpartum Depression (PPD) Treatment Market

  • The global postpartum depression (PPD) treatment market is primarily driven by launch of new products, recent product approvals from regulatory bodies such as the Food and Drug Administration (FDA), and increase in awareness about PPD
  • In March 2019, the FDA granted approval for Zulresso (brexanolone) injection for the treatment of postpartum depression (PPD) in adult women. The drug is manufactured by Sage Therapeutics, Inc., a pharmaceutical company based in the U.S.
  • Additionally, non-government organizations undertake a number of awareness programs for PPD which enable women to gain knowledge about the condition and avoid complications during child birth

Selective Allosteric Modulators of Gamma-Aminobutyric Acid Type A (GABA (A)) Receptor Segment to Capture Significant Market Share

  • Based on drug class, the global postpartum depression (PPD) treatment market can be classified into selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitor (SNRI), and selective allosteric modulators of gamma-aminobutyric acid type A (GABA(A)) receptor
  • The selective allosteric modulators of gamma-aminobutyric acid type A (GABA(A)) receptor segment is anticipated to capture significant share of the global postpartum depression (PPD) treatment market during the forecast period, owing to launch of branded drugs in this drug class and rise in adoption of new therapies for PPD.

Branded Segment to Account for Major Share of Global Postpartum Depression (PPD) Treatment Market

  • In terms of drug type, the global postpartum depression (PPD) treatment market can be bifurcated into branded and generics. The branded segment is projected to account for the largest market share due to increase in availability of branded drugs. However, high cost of these drugs is likely to restrain the segment.

Oral Segment to Offer Significant Opportunities in Global Postpartum Depression (PPD) Treatment Market

  • Based on route of administration, the global postpartum depression (PPD) treatment market can be categorized into oral and intravenous
  • The oral segment is expected to account for major share of the global postpartum depression (PPD) treatment market by 2027. The segment is projected to be driven by high availability of orally administered drugs in the form of tablets, capsules, and oral solution.

Hospital Pharmacies Segment to Capture Significant Share of Global Postpartum Depression (PPD) Treatment Market

  • In terms of distribution channel, the global postpartum depression (PPD) treatment market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacies segment is anticipated to offer significant opportunities, especially in the developed countries in North America and Europe.

Looking for Regional Analysis or Competitive Landscape in Postpartum Depression (PPD) Treatment Market, Ask for a Customized Report

North America to Dominate Global Postpartum Depression (PPD) Treatment Market

  • In terms of region, the global postpartum depression (PPD) treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global postpartum depression (PPD) treatment market during the forecast period.
  • Rise in prevalence of postpartum depression in the U.S. and strengthening R&D efforts by market players are likely to drive the market in North America during the forecast period
  • According to the PostpartumDepression.org, 70% to 80% of women in the U.S. are likely to experience postpartum depression

Key Players Operating in Global Postpartum Depression (PPD) Treatment Market

The global postpartum depression (PPD) treatment market is highly fragmented, with a large number of domestic players accounting for major market share. Key players operating in the global postpartum depression (PPD) treatment market are:

  • Sage Therapeutics
  • Pfizer, Inc.
  • Allergan
  • Eli Lilly and Company
  • Sebela Pharmaceuticals, Inc.
  • GlaxoSmithKline
  • Mylan N.V.

Global Postpartum Depression (PPD) Treatment Market: Research Scope

Global Postpartum Depression (PPD) Treatment Market, by Drug Class

  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
  • Selective Allosteric Modulators of Gamma-Aminobutyric Acid type A (GABA(A)) Receptor

Global Postpartum Depression (PPD) Treatment Market, by Drug Type

  • Branded
  • Generic

Global Postpartum Depression (PPD) Treatment Market, by Route of Administration

  • Oral
  • Intravenous

Global Postpartum Depression (PPD) Treatment Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Postpartum Depression (PPD) Treatment Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Postpartum Depression (PPD) Treatment Market